Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial

Shu-Huai Tsai1, Guangrong Lu2, Xin Xu1

  • 1Department of Medical Physiology, Texas A&M University Health Science Center, Temple, TX, USA.

Insights

Pressure overload causes cardiac hypertrophy, leading to coronary microvascular dysfunction and ischemia. This is linked to oxidative stress, endothelin-1 (ET-1) vasoconstriction, and impaired nitric oxide (NO) function via elevated rho-kinase (ROCK) signaling.

Area of Science:

  • Cardiovascular Physiology
  • Vascular Biology
  • Cardiac Pathophysiology

Background:

  • Hypertensive cardiac hypertrophy impairs coronary flow reserve.
  • The precise mechanisms affecting coronary flow regulation and vasomotor function are not fully understood.

Purpose of the Study:

  • To investigate the impact of pressure overload-induced cardiac hypertrophy on coronary microvascular function and regulation in a mouse model.
  • To explore the roles of endothelin-1 (ET-1), rho-kinases (ROCKs), and oxidative stress in this dysfunction.

Main Methods:

  • Left ventricular hypertrophy was induced in mice via transverse aortic coarctation (TAC).
  • Coronary microvascular function was assessed by measuring coronary arteriolar responses to acetylcholine (ACh) and ET-1.
  • Myocardial and vascular oxidative stress markers and ROCK expression were evaluated.

Main Results:

  • TAC mice exhibited increased heart-to-body weight ratio, reduced cardiac function, and impaired coronary blood flow response to isoproterenol.
  • Coronary arterioles from TAC mice showed reversed nitric oxide (NO)-mediated dilation to ACh and augmented vasoconstriction to ET-1.
  • Elevated myocardial ET-1, increased vascular ROCK expression, and heightened oxidative stress were observed in TAC mice.

Conclusions:

  • Pressure overload-induced myocardial hypertrophy leads to cardiac and coronary microvascular dysfunction and ischemia.
  • This dysfunction is potentially mediated by oxidative stress, enhanced ET-1 vasoconstriction, and compromised endothelial NO function.
  • Elevated ROCK signaling plays a critical role in these pathological changes, suggesting it as a therapeutic target.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
574